Trials / Completed
CompletedNCT01560702
Comparative Study of Autologous Blood Injection Versus Diluted Epinephrine in Treating Actively Bleeding Gastroduodenal Ulcers
Endoscopic Injection of Autologous Blood Versus Diluted Epinephrine for Control of Actively Bleeding Gastroduodenal Ulcers
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Zagazig University · Other Government
- Sex
- All
- Age
- 16 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Endoscopic injection of autologous blood can control bleeding from gastroduodenal ulcers.
Detailed description
To test the hypothesis that endoscopic injection of autologous blood is superior to endoscopic injection of diluted epinephrine in controlling bleeding from gastroduodenal ulcers.
Conditions
- Blood, Injection, Injury Type Phobia
- Gastrointestinal Ulcer Haemorrhage
- Adverse Reaction to Epinephrine
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Epinephrine | 10-30 cc of 1/10000 diluted epinephrine will be injected at edges of an actively bleeding ulcer. |
| BIOLOGICAL | Blood | 5-20 cc autologous blood immediately withdrawn from the patient will be injected at edges of the actively bleeding ulcer. |
Timeline
- Start date
- 2012-03-01
- Primary completion
- 2013-09-01
- Completion
- 2013-09-01
- First posted
- 2012-03-22
- Last updated
- 2013-09-25
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT01560702. Inclusion in this directory is not an endorsement.